NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism-Reference-Cited by-同舟云学术

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

Published:2008-11-03 Issue:11 Volume:118 Page:3775-3789
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Aliprantis Antonios O.,Ueki Yasuyoshi,Sulyanto Rosalyn,Park Arnold,Sigrist Kirsten S.,Sharma Sudarshana M.,Ostrowski Michael C.,Olsen Bjorn R.,Glimcher Laurie H.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference78 articles.

1. United States Department of Health and Human Services. 2004. Bone health and osteoporosis: a report of the Surgeon General. http://www.surgeongeneral.gov/library/bonehealth/content.html .

2. Increased Myeloid Cell Responses to M-CSF and RANKL Cause Bone Loss and Inflammation in SH3BP2 “Cherubism” Mice

3. Pathogenesis of bone erosions in rheumatoid arthritis

4. RANKL–RANK signaling in osteoclastogenesis and bone disease

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptomic insights into chemotherapy-induced remodeling of the osteosarcoma tumor microenvironment;Journal of Cancer Research and Clinical Oncology;2024-07-20

2. The G9a histone methyltransferase represses osteoclastogenesis and bone resorption by regulating NFATc1 function;The FASEB Journal;2024-07-05

3. Trifolirhizin protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption;Heliyon;2024-07

4. NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling;Endocrinology;2024-07-01

5. pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration;International Journal of Nanomedicine;2024-06